Form 10-K405/A - Annual report [Sections 13 and 15(d), S-K Item 405]: [Amend]
SEC Accession No. 0000942794-98-000024
Filing Date
1998-10-02
Accepted
1998-10-02 00:00:00
Documents
2
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 10-K405/A 17406
2 EX-27 4277
  Complete submission text file 0000942794-98-000024.txt   23407
Mailing Address 365 PLANTATION STREET WORCESTER MA 01605
Business Address 175 CROSSING BLVD BIOTECHNOLOGY RESEARCH PARK FRAMINGHAM MA 01605 5087975777
AQUILA BIOPHARMACEUTICALS INC (Filer) CIK: 0000704292 (see all company filings)

EIN.: 043307818 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405/A | Act: NE | File No.: 000-12081 | Film No.: 98720107
SIC: 2835 In Vitro & In Vivo Diagnostic Substances